Mineralys Therapeutics, Inc.
MLYS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001933414
In the last 90 days, Mineralys Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 225 institutions reported holding it in 13F filings for Q2 2026, worth $2.69B in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Mineralys Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 68 | 77 | +9 |
| Shares | 25.2M | 26.5M | +1.33M (+5.3%) |
| Value | $429.2M | $252.1M | −$177.1M (−41.3%) |
New holders (22)
Institutions that held Mineralys Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| CHI Advisors LLC | 568,379 | $5.41M | 2.14% |
| Millennium Management LLC | 364,343 | $3.46M | 0.00% |
| Renaissance Technologies LLC | 95,690 | $910.0K | 0.00% |
| Jane Street Group, LLC | 43,057 | $409.5K | 0.00% |
| Raymond James Financial Services Advisors, Inc. | 40,578 | $385.9K | 0.00% |
| Two Sigma Investments, LP | 36,103 | $343.3K | 0.00% |
| Jump Financial, LLC | 32,700 | $311.0K | 0.01% |
| Occudo Quantitative Strategies LP | 22,489 | $213.9K | 0.03% |
| XTX Topco Ltd | 18,670 | $177.6K | 0.03% |
| Citadel Advisors LLC | 18,616 | $177.0K | 0.00% |
| Walleye Capital LLC | 15,255 | $145.1K | 0.00% |
| PDT Partners, LLC | 13,912 | $132.3K | 0.02% |
| Russell Investments Group, Ltd. | 10,180 | $96.8K | 0.00% |
| CWM, LLC | 2,678 | $25.0K | 0.00% |
| Allspring Global Investments Holdings, LLC | 1,663 | $15.8K | 0.00% |
| Riverview Trust Co | 1,353 | $12.9K | 0.01% |
| Umb Bank N A | 1,046 | $9.95K | 0.00% |
| Comerica Bank | 513 | $4.88K | 0.00% |
| Cubist Systematic Strategies, LLC | 485 | $4.61K | 0.00% |
| Qube Research & Technologies Ltd | 463 | $4.40K | 0.00% |
| Huntington National Bank | 166 | $1.54K | 0.00% |
| The PNC Financial Services Group, Inc. | 23 | $219 | 0.00% |
Sold out (13)
Institutions that held Mineralys Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 837,000 | $14.3M |
| Avidity Partners Management LP | 766,700 | $13.1M |
| Great Point Partners LLC | 546,059 | $9.31M |
| Jennison Associates LLC | 355,475 | $6.06M |
| Bank of Montreal | 101,724 | $1.51M |
| Pentwater Capital Management LP | 80,000 | $1.36M |
| Soleus Capital Management, L.P. | 76,817 | $1.31M |
| Affinity Asset Advisors, LLC | 62,500 | $1.07M |
| Prudential Financial Inc | 50,770 | $865.6K |
| Panagora Asset Management Inc | 23,016 | $392.4K |
| Goldman Sachs Group Inc | 16,326 | $278.4K |
| Parkman Healthcare Partners LLC | 11,658 | $198.8K |
| Versant Capital Management, Inc | 32 | $546 |